Recent Development of Quinoline Derivatives as Anticancer Agents: 2015–2022
Authors:
- 2 February 2023
- book chapter
- Published by Springer Nature
- p. 217-250
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitorsEuropean Journal of Medicinal Chemistry, 2017
- Quinolino[3,4- b ]quinoxalines and pyridazino[4,3- c ]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic propertiesEuropean Journal of Medicinal Chemistry, 2016
- Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitorsEuropean Journal of Medicinal Chemistry, 2016
- Amino substituted benzimidazo[1,2- a ]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding propertiesEuropean Journal of Medicinal Chemistry, 2016
- Synthesis and biological evaluation of 6-fluoro-3-phenyl-7-piperazinyl quinolone derivatives as potential topoisomerase I inhibitorsEuropean Journal of Medicinal Chemistry, 2016
- 2-(Phenylsulfonyl)quinoline N -hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylaseEuropean Journal of Medicinal Chemistry, 2016
- Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitorsEuropean Journal of Medicinal Chemistry, 2016
- Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitorsEuropean Journal of Medicinal Chemistry, 2016
- Symptoms and signs in patients with colorectal cancerColorectal Disease, 2010
- Symptom clusters in patients with advanced cancersSupportive Care in Cancer, 2009